Lone B.
- Country
- Denmark
- Department
- Bispebjerg
Research Overview
- Efficacy of Sublingual Dexmedetomidine and Buccal Midazolam Versus Oral Lorazepam for Acute Agitation Management in Emergency Psychiatry
- Efficacy of Cannabidiol and Risperidone in Treating Non-Affective Psychosis and Cannabis Use: A Randomized Controlled Trial
- Efficacy of Melatonin and Low-Dose Quetiapine Versus Placebo in Patients with Psychiatric Disorders and Comorbid Insomnia: A Randomized Clinical Trial
Data & Insights
Has run more than one trial at 1 of 1 partner site.
Specializations
Sleep Medicine & Psychiatry
This investigator specializes in treating psychiatric disorders with comorbid insomnia, exploring various therapeutic approaches including melatonin and quetiapine interventions. Their work addresses sleep disturbances in patients with complex psychiatric conditions.
- Insomnia Treatment
- Sleep-Psychiatric Comorbidities
- Sleep Medicine
The research encompasses both adolescent and adult populations with psychiatric disorders requiring sleep intervention.
Emergency Psychiatry
The investigator focuses on advancing treatment protocols for acute agitation in emergency psychiatric settings, evaluating rapid-acting interventions including sublingual dexmedetomidine and buccal midazolam.
- Acute Tranquilization
- Emergency Mental Health
- Crisis Intervention
Their work aims to improve immediate care responses in acute psychiatric emergencies.
Novel Therapeutic Approaches
The investigator explores innovative treatments for non-affective psychosis, with particular attention to cannabidiol (CBD) applications. Their research extends to patients with concurrent cannabis use history.
- Psychosis Treatment
- Alternative Therapeutics
- Substance Use Disorders
Their work investigates new therapeutic pathways for complex psychiatric conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.